Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0025343259
Thu, 18.01.2024
COLTENE Holding AG
COLTENE Holding AG, a leading international developer and manufacturer of dental consumables and small equipment, publishes key figures for the financial year 2023. Net sales are expected to amount to CHF 242.6 million. The operating result is anticipated to close with a margin of approximately 8%. Dominik Arnold took over the position of CEO of th [ … ]
Fri, 08.09.2023
COLTENE Holding AG
The Board of Directors of the COLTENE group, a leading international developer and manufacturer of dental consumables and small equipment, has appointed Dominik Arnold (51) to become the new CEO of the COLTENE group as of 1 January 2024. Dominik Arnold succeeds Martin Schaufelberger (59) who will step down from operations at the end of the year.
[ … ]
Fri, 04.08.2023
COLTENE Holding AG
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, achieved a pleasing business performance in the first half (H1) of 2023 despite a challenging business environment. Net sales were up 1.7% year-on-year, at constant exchange rates, outperforming the strong result of the same period a year earlier. [ … ]
Fri, 03.03.2023
COLTENE Holding AG
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to [ … ]
Fri, 03.03.2023
COLTENE Holding AG
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to [ … ]
Fri, 03.03.2023
COLTENE Holding AG
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to [ … ]
Fri, 03.03.2023
COLTENE Holding AG
COLTENE achieved sales of CHF 267.1 million, down 4.3%.
Operating profit (EBIT) reached CHF 34.9 million (2021: CHF 43.8 million).
Operating profit margin 2022 was 13.1% (2021: 15.7%).
Net Income was CHF 26.0 million (2021: CHF 31.7 million).
The Board of Directors proposes a dividend of CHF 3.30 per share from capital contribution reserves to [ … ]
Fri, 20.01.2023
COLTENE Holding AG
Ad hoc announcement pursuant to Art. 53 LR
COLTENE, a leading international developer and manufacturer of dental consumables and small equipment, announces its first key figures for the 2022 financial year. Compared to the previously anticipated sales at the level of the 2021 business year (CHF 279.2 million), the company is expected to achieve sal [ … ]
Fri, 05.08.2022
COLTENE Holding AG
Ad hoc announcement pursuant to Art. 53 LR
First-half (H1) 2022 results are in the upper range of preliminary figures announced in late June. These had indicated that the upward trend in new orders would be impacted by the global supply chain constraints. COLTENE was therefore unable in H1 to derive full benefit from the strong market demand. Again [ … ]
Fri, 05.08.2022
COLTENE Holding AG
Ad hoc announcement pursuant to Art. 53 LR
First-half (H1) 2022 results are in the upper range of preliminary figures announced in late June. These had indicated that the upward trend in new orders would be impacted by the global supply chain constraints. COLTENE was therefore unable in H1 to derive full benefit from the strong market demand. Again [ … ]